Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptive Biotechnologies Corp

10.75
+0.09000.84%
Post-market: 10.750.00000.00%19:09 EDT
Volume:1.39M
Turnover:14.89M
Market Cap:1.63B
PE:-11.21
High:10.85
Open:10.73
Low:10.54
Close:10.66
Loading ...

Adaptive Biotechnologies Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
02 May

Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks
·
02 May

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
02 May

Stock Track | Adaptive Biotechnologies Soars 5.98% After Hours on Strong Q1 2025 Earnings Beat

Stock Track
·
02 May

Stock Track | Adaptive Biotechnologies Soars 5.98% After-Hours on Strong Q1 Results, Beating Estimates

Stock Track
·
02 May

Adaptive Biotechnologies: Q1 Earnings Snapshot

Associated Press Finance
·
02 May

BRIEF-Adaptive Biotechnologies Q1 EPS USD -0.2

Reuters
·
02 May

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results

GlobeNewswire
·
02 May

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

GlobeNewswire
·
11 Apr

Adaptive Biotechnologies' Mantle Cell Lymphoma Test Receives Expanded Medicare Coverage

MT Newswires Live
·
08 Apr

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Adaptive Biotechnologies (ADPT) and Alnylam Pharma (ALNY)

TIPRANKS
·
31 Mar

Adaptive Biotechnologies Gains Following Goldman Sachs Upgrade, Share Climb 6% Near Friday Close

MT Newswires Live
·
22 Mar

Adaptive Biotechnologies Raised to Buy From Neutral by Goldman Sachs

Dow Jones
·
21 Mar

Goldman Sachs Upgrades Adaptive Biotechnologies to Buy From Neutral, Adjusts Price Target to $9 From $8

MT Newswires Live
·
21 Mar

Adaptive Biotechnologies (ADPT) Gets a Buy from BTIG

TIPRANKS
·
18 Mar

Adaptive Biotechnologies launches assay enhancements for clonoSeq

TIPRANKS
·
11 Mar

Catherine Wood's Strategic Reduction in Adaptive Biotechnologies Corp Shares

GuruFocus
·
15 Feb

Adaptive Biotechnologies Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
14 Feb

Stock Track | Adaptive Biotechnologies Soars 5% in Pre-Market as Full Year Earnings Beat Expectations

Stock Track
·
13 Feb

Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank

TIPRANKS
·
13 Feb